Article

Fish Oil, Green Tea, and Prostate Cancer Prevention

Fatty acid synthase (FAS) is a lipogenic multienzyme that catalyzes the final step in de novo fatty acid synthesis. Recently, FAS has been characterized as an oncogene and is overexpressed in various tumor types including prostate. FAS expression does not appear to be regulated by nutritional controls. However, when omega-3 fatty acid (w-3 FA) and docosahexanoic acid (DHA) are added, FAS expression appears to be inhibited.

To view research abstract, click here.

Related Videos
Diabetes Dialogue: Exploring New Horizons in Incretin Therapy for Diabetes and Weight Loss | Image Credit: HCPLive
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
4 experts are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.